Data / Form D filings / InterVene, Inc.
InterVene, Inc.: Form D filings
InterVene, Inc., a health care company in South San Francisco, CA, filed 4 Form D notices with the SEC between 2015 and 2023. The latest, on March 7, 2023, reports $1.5 million sold of a $3 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 415 Grand Avenue, Suite 302, South San Francisco, CA, 94080
- Phone
- (650) 351-6725
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1637074
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | New notice | $3,000,000 | $1,504,488 | $1,495,512 | 6 | Feb 21, 2023 | sec.gov |
| Mar 7, 2023 | New notice | $3,000,000 | $1,504,488 | $1,495,512 | 6 | Feb 21, 2023 | sec.gov |
| Jun 7, 2017 | New notice | $3,000,000 | $2,160,944 | $839,056 | 17 | May 11, 2017 | sec.gov |
| Mar 19, 2015 | New notice | $7,215,000 | $5,923,731 | $1,291,269 | 52 | Mar 16, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ginger Glaser | Director | |
| Fletcher Wilson | Director | |
| Jay Schmelter | Director | |
| Adam Berman | Director | |
| Catherine L. Matthes | Executive Officer | |
| Joe Biller | Director | |
| Jeffrey Elkins | Executive Officer, Director |
Other health care companies in California that filed recently
- VERIONYX, INC. offering · Oct 26, 2026
- RCE Technologies, Inc. $110,000 · Oct 23, 2026
- Gale Force Aesthetics, Inc. $800,000 · Oct 22, 2026
- VahatiCor, Inc. $30.4 million · Oct 20, 2026
- Lamina Surgical, Inc. $490,000 · Oct 16, 2026
- Ellipsys Medical, Inc. $8.6 million · Oct 14, 2026
Every Form D from the week of Mar 6, 2023 · All recent filings in California · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what InterVene, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.